Listen, unless you can provide me the research papers of these trails that state otherwise, we can freely assume that every single fucking AR event in the study is "the development of any singular meaningfully disruptive health effect due to Covid-19 infection", with a cap of 1 AR per person. In other words, every notable infection is counted regardless of its severity unless its asymptomatic.
RRR is the efficacy rate of the treatment itself.
ARR is the incidence reduction rate across the entire population, in other words, not the efficacy rate of the treatment itself but the efficacy rate of what a population wide rollout would look like.
This means that 95% is 95% is 95%. Really no other way to state it. If you, as a person, take the vaccine, your chance of suffering from a meaningfully disruptive health effect in the event you are exposed to COVID is 1/20th of what it used to be. Yes, your chances of actually getting exposed to it are highly variable and by factoring in this chance you can get an overview of what the efficacy of the vaccine could be at slowing down the spread.
And that wasn't what I stated. What I stated was "if you don't know the context of the control pool you cannot ascertain how meaningful the ARR is". Certainly there are analysis where ARR relates to the health of the control group but this only factors in whenever we are looking at specific health complications of a condition rather than the appearance of the condition to begin with. You'd have a point if this ARR analysis was looking at treatment options for active covid cases rather than preventative measures, but it doesn't, so you don't. Which means that in this case, ARR only and strictly refers to the risk of infectivity in your region at that specific time, which means it will vary wildly.
That being said, ARR in this way does actually inform the default vaccine package in most nations. For example, western countries typically don't have a yellow fever vaccine, because our the ARR on a population wide rollout is so phenomenally small as to not warranting even mentioning; we are talking like a one in a million shift, despite the yellow fever vaccine being one of the most reliable in the world. In third world nations within the tropical regions where the mosquitos that have the disease live, however, we are most likely looking at a .1 ARR (which, for the record, is still considerably lower than what you've stated here, though yellow fever is of course a lot more dangerous than covid)
....Ah for the love of....
Listen, unless you can provide me the research papers of these trails that state otherwise, we can freely assume that every single fucking AR event in the study is "the development of any singular meaningfully disruptive health effect due to Covid-19 infection", with a cap of 1 AR per person. In other words, every notable infection is counted regardless of its severity unless its asymptomatic.
RRR is the efficacy rate of the treatment itself. ARR is the incidence reduction rate across the entire population, in other words, not the efficacy rate of the treatment itself but the efficacy rate of what a population wide rollout would look like.
This means that 95% is 95% is 95%. Really no other way to state it. If you, as a person, take the vaccine, your chance of suffering from a meaningfully disruptive health effect in the event you are exposed to COVID is 1/20th of what it used to be. Yes, your chances of actually getting exposed to it are highly variable and by factoring in this chance you can get an overview of what the efficacy of the vaccine could be at slowing down the spread.
And that wasn't what I stated. What I stated was "if you don't know the context of the control pool you cannot ascertain how meaningful the ARR is". Certainly there are analysis where ARR relates to the health of the control group but this only factors in whenever we are looking at specific health complications of a condition rather than the appearance of the condition to begin with. You'd have a point if this ARR analysis was looking at treatment options for active covid cases rather than preventative measures, but it doesn't, so you don't. Which means that in this case, ARR only and strictly refers to the risk of infectivity in your region at that specific time, which means it will vary wildly.
That being said, ARR in this way does actually inform the default vaccine package in most nations. For example, western countries typically don't have a yellow fever vaccine, because our the ARR on a population wide rollout is so phenomenally small as to not warranting even mentioning; we are talking like a one in a million shift, despite the yellow fever vaccine being one of the most reliable in the world. In third world nations within the tropical regions where the mosquitos that have the disease live, however, we are most likely looking at a .1 ARR (which, for the record, is still considerably lower than what you've stated here, though yellow fever is of course a lot more dangerous than covid)